Company · CIK 0001095435 · SIC 6199 — Finance Services · Nasdaq
Alpha Compute Corp · ALP
Insider activity reported against this company. All insider holders · Files at: BHVN. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 PForm 4 → | Sep 23, 4:37 pm EDT | Fiorenzo VillaniSee Remarks, Director | 10,000 | $4.40 | $44,047 | 48,886 | +25.7% | |
| Sep 14, 2026 PForm 4 → | Sep 17, 6:25 pm EDT | Fiorenzo VillaniSee Remarks, Director | 26,547 | $4.11 | $108,987 | 11,917 | — | late |
| Sep 9, 2026 PForm 4 → | Sep 14, 7:27 am EDT | Fiorenzo VillaniSee Remarks, Director | 7,000 | $5.07 | $35,455 | 22,219 | +46.0% | late |
| Sep 9, 2026 PForm 4 → | Sep 14, 7:25 am EDT | Brittany KaiserChief Executive Officer, Director | 9,350 | $5.35 | $49,997 | 16,766 | +126% | late |
| Sep 9, 2026 PForm 4 → | Sep 11, 8:39 pm EDT | Wesley Allen LevittChief Financial Officer | 1,000 | $5.10 | $5,096 | 1,000 | — | |
| Apr 29, 2026 AForm 4 → | Sep 14, 7:27 am EDT | Fiorenzo VillaniSee Remarks, Director | 24,094 | — | — | 11,735 | — | late |
| Apr 29, 2026 AForm 4 → | Sep 14, 7:25 am EDT | Brittany KaiserChief Executive Officer, Director | 7,416 | — | — | 7,416 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2026 AForm 4 → | Sep 14, 7:27 am EDT | Fiorenzo VillaniSee Remarks, Director | 10,906 | — | — | 10,906 | — | late |
| May 14, 2026 AForm 4 → | Sep 14, 7:25 am EDT | Brittany KaiserChief Executive Officer, Director | 10,906 | — | — | 10,906 | — | late |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2018 SForm 4/A → | Jan 25, 4:13 pm EST | Biohaven Pharmaceutical Holding Co Ltd.BHVN | 59,396 | $31.31 | $1,859,406 | 54,494 | −52.2% | plan? |
| Jan 19, 2018 SForm 4 → | Jan 24, 7:01 pm EST | Biohaven Pharmaceutical Holding Co Ltd.BHVN | 59,396 | $135,520.34 | $8,049,365,832 | 54,494 | −52.2% | plan? late amended |
| Jan 5, 2018 SForm 4 → | Jan 9, 6:23 pm EST | Biohaven Pharmaceutical Holding Co Ltd.BHVN | 84,881 | $30.06 | $2,551,573 | 6,216,619 | −1.35% | plan? |
| Jan 4, 2018 SForm 4/A → | Jan 11, 11:06 am EST | Biohaven Pharmaceutical Holding Co Ltd.BHVN | 4,350 | $28.62 | $124,504 | 6,301,500 | −0.07% | plan? |
| Jan 4, 2018 SForm 4 → | Jan 5, 10:29 am EST | Biohaven Pharmaceutical Holding Co Ltd.BHVN | 4,350 | $28.62 | $124,504 | 124,371 | −3.38% | plan? amended |
| Jan 3, 2018 SForm 4 → | Jan 4, 4:15 pm EST | Biohaven Pharmaceutical Holding Co Ltd.BHVN | 35,650 | $28.61 | $1,020,071 | 6,305,850 | −0.56% | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.